Healixa (OTC:EMOR), Inc. a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water, and green-tech industries, has announced that former US representative Denver Riggleman will join its board of directors.
"As we prepare this company to move to the next level in the public markets it is important that we continue to add diverse expertise and insight to our board,” Healixa (OTC:EMOR) CEO Ian Parker said in a statement.
"Healixa (OTC:EMOR) highly values the broad range of experience that Rep. Riggleman brings to our board. His experience in government, defense, national security, and executive management will be invaluable to our company's growth and development,” he added.
WATCH: Healixa advancing its atmospheric water harvesting tech to provide clean water to anyone, anywhere
Healixa (OTC:EMOR) noted that Congressman Riggleman served as the US Representative for Virginia's 5th congressional district. He is an Air Force veteran and national security expert, as well as a successful businessman and founder of Silverback Distillery.
His background as an intelligence officer included mission planning during the bombing of Afghanistan after the September 11 attacks. In addition, he was CEO of Analyst Warehouse, a company that contracted with the National Security Agency, from 2007 to 2015, the company added.
"Creating technologies with a vision toward lifting others up and preserving our environment is a mission I'm proud to support,” Riggleman said.
“Ethical engineering is the future. I am delighted to take this journey alongside Healixa's other board members, employees and global citizens."
Riggleman replaces Matthew Dill, who is stepping down from the company’s board.
“Even though my primary focus has changed, my commitment and support for Healixa has never been stronger,” Dill said.
“Although I will not be serving as a board member, I will be doing whatever I can to support the company's future. I know Denver will be able to provide significant value to Healixa. That is why I supported both his nomination and appointment to the seat I'm leaving.”
Contact the author at stephen.gunnion@proactiveinvestors.com